Biosketch

Judith Berman, Ph.D., is Professor and Nathan Galston Chair of Antimicrobial Drug Research and Director of the Center for Genome Stability and Fungal Tolerance at Tel Aviv University, and Distinguished McKnight University Professor Emerita at the University of Minnesota. She earned her BSc from the College of Agriculture and Life Sciences at Cornell University, her PhD in biochemistry at the Weizmann Institute of Science and conducted postdoctoral research in molecular genetics at Cornell University. She joined the faculty of the University of Minnesota College of Life Sciences in 1986. In 2012, she moved her lab to Tel Aviv University, joining the George S. Wise Faculty of Life Sciences, where she is an active member of the Shmunis School of Biomedicine and Cancer Research. She is also an Honorary Professor at the MRC Center for Medical Mycology at the University of Exeter, in the United Kingdom, a member of the European Molecular Biology Organization (EMBO), the American Academy of Arts and Sciences, and the NAS, as well as a fellow of the American Academy for the Advancement of Science and the American Academy of Microbiology.

Research Interests

Prof. Berman’s research on pathogenic yeasts, especially Candida albicans and Candida glabrata, seeks to understand basic processes, including drug tolerance, whereby pathogens grow in drugs despite their general drug-susceptibility. Her lab studies the mechanisms that underlie stress responses by exploring molecular and metabolic changes that alter the growth of subpopulations of cells that exhibit resilience to drug exposure. They also study dynamics of chromosomal structures, including centromeres, telomeres, origins of replication, and repeated DNA regions, and their contributions to genome stability and stress resiliance. Berman and colleagues have developed and adapted many widely used resources for the community of Candida researchers, including epitope and fluorescent protein tags and tools for analyzing and visualizing the genome structure of individual isolates. Understanding pathogen resiliance, and the chromosomal changes that sometimes drive it, may point the way to new therapeutic treatments for fungal infections.

Related Links

Membership Type

Member

Election Year

2026

Primary Section

Section 44: Microbial Biology

Secondary Section

Section 26: Genetics